drugset / Trial / NCT01411098

Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT01411098 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase I trial studies the side effects and best dose of radiation therapy when given together with cisplatin and etoposide in treating patients with non-small cell lung cancer that cannot be removed by surgery. Radiation therapy uses high energy x rays to kill tumor cells. Drugs used in chemotherapy, such as cisplatin and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Drugs, such as cisplatin, may make tumor cells more sensitive to radiation therapy. Giving radiation therapy together with cisplatin and etoposide may kill more tumor cells.

Timeline

Start
2011-10
Primary completion
2015-03
Completion
—

Outcome

Outcome not reported

Stopped (Enrollment): “Low accrual”

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified — Intravenous
Background Etoposide Small molecule — Intravenous